tuberculosis antigens, combined with synthetic toll-like receptor 4 (TLR4) agonist glucopyranosyl lipid adjuvant (GLA) in a stable nano-emulsion (SE) has been developed and is known as ID93/GLA-SE [214]. The gene discussed is TLR4; the disease is tuberculosis.